NCT06134934Active, not recruiting
TeleCare North Diabetes
TeleCare North Diabetes: A Feasibility Study
Source: ClinicalTrials.gov · Last updated 1 Oct 2025
Brief summary (registry, in English)
This feasibility study will evaluate the feasibility of two telemonitoring designs for non-insulin treated T2D patients with an eye to identify the most suitable telemonitoring intervention for a future large-scale randomized trial.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 1 Nov 2023
- Start date
- 9 Jan 2024
- Primary completion date
- 1 May 2025
- Lead sponsor
- Aalborg University Hospital
- Diseases
- Type 2 diabetes
- NCT number
- NCT06134934
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 9 Jan 2024 to the primary completion date, 1 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe diabetes complications such as severe neuropathy or nephropathy (dialysis treatment)
- Participation in diabetes rehabilitation courses
Other
- Pregnancy or breastfeeding
- Insulin treatment
- Prednisolone treatment
- Participation in other intervention trials
- Terms that, in the opinion of the sub-investigator or investigator, render the participant unfit to conduct the trial, including lack of understanding of the trial or lack of physical or cognitive ability to participate
Who the study is looking for
- Women and men ≥ 18 years
- Poorly controlled T2D, i.e. HbA1c \> 58 mmol/mol
- Diagnosis of T2D for at least 12 months
- General Practitioner responsible for diabetes treatment
- Residence in Hjørring, Morsø, Jammerbugt, or Rebild municipality
- Ability and willingness to use a smartphone/tablet along with the other devices to be used in the trial
- Signed informed consent
- Ability to understand and read Danish
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Steno Diabetes Center North Denmark Coordinator of this site? Confirm its status | Aalborg | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.